Alamar Biosciences Inc. (ALMR:NASDAQ) closed at $25.58 on October 19, 2026, up 1.19% on the day. The stock trades 35.4% below its 52-week high of $39.61 and 35.7% above its 52-week low of $18.85. Over the past year, it gained 14.9%. Alamar Biosciences Inc. is part of the Health Care sector.
| 5D | 1M | 3M | 6M | 1Y |
|---|---|---|---|---|
| +4.29% | -21.02% | +5.69% | +14.91% | +14.91% |
In 126 trading sessions since April 20, 2026, ALMR closed higher on 63 days (50%). Its best day was August 11, 2026 (+30.65%) and its worst was October 6, 2026 (-15.39%). The stock moved 10% or more in a single session 5 times.
Alamar is a life sciences company dedicated to powering precision proteomics to enable the earliest detection of disease. Leveraging its proprietary NULISA¿ technology and the ARGO¿ HT System, Alamar's platform is designed to detect biomarkers with ultra-high sensitivity and address key limitations of existing technologies, helping researchers unlock the full spectrum of protein biomarkers across disease states.
Find more stocks like ALMR with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.